Update

Online Webcast Provides a Hypertension Update

by

OSUWexnerbloglogo2014 Online Webcast Provides a Hypertension Update. For this CME webcast, we’re going to discuss the most recent guidelines from the American College of Cardiology and the American Heart Association in regard to hypertension. We’re pleased to welcome Assistant Professor of Internal Medicine at The Ohio State University, Dr. Aaron Friedberg.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: appropriately define and diagnose hypertension in adults; and appropriately manage hypertension in adults in the outpatient setting.

You’ll also learn about the following:

  • Making the Diagnosis of Hypertension
  • Modifiable Risk Factors
  • Increasing dose or advancing to a second drug
  • Hypertensive Urgency

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Experts Discuss Genetic Disease Update on Webcast

by

OSUWexnerbloglogo2014 Experts Discuss Genetic Disease Update on Webcast. On this CME webcast, we’re going to get an update on how clinical genetics is improving the outcomes and survival of patients with breast cancer and heart failure. We’re pleased to welcome this week’s guests. Kevin Sweet is a genetics counselor and Professor in the Department of Internal Medicine and he is going to discuss breast cancer genetics. And Elizabeth Jordan is a genetics counselor and Assistant Professor of Internal Medicine who will be talking about the genetics of cardiomyopathy.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: define hereditary breast ovarian cancer syndrome; provide a case example of genetic/genomic testing and management of a patient and family with hereditary breast ovarian cancer syndrome; describe the current state of the genetics of dilated cardiomyopathy (DCM), including (1) list clinically relevant DCM genes, (2) outline the Genetic Testing process for DCM, and (3) discuss the guidelines for the family-based genetic evaluation of cardiomyopathy; explore a genetic DCM case example; and consider future directions of DCM genetics.

You’ll also learn about the following:

  • Epidemiology of inherited breast cancer
  • Epidemiology of inherited cardiomyopathy

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Get An Update on Antibiotics on CME Webcast

by

OSUWexnerbloglogo2014 Get An Update on Antibiotics on CME Webcast. Today on OSU MedNet, we are going to update you on some of these new antibiotics. Let me welcome today’s guest, Dr. Sydney Agnello. She is an infectious disease expert and Assistant Professor of Internal Medicine from the Ohio State University.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: enhance knowledge of clinical use of well-known antibiotics; and enhance understanding of newer antibiotics available and when they may be used clinically.

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Provides Asthma Update

by

OSUWexnerbloglogo2014 CME Webcast Provides Asthma Update. To update us on the latest in asthma treatments, we’re pleased to welcome two of the Ohio State University’s top asthma specialists. Dr. Megan Conroy is a pulmonologist and Assistant Professor of Internal Medicine. And Dr. Gennie Wang is also an Assistant Professor of Internal Medicine from the Division of Pulmonary and Critical Care Medicine.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: describe outcomes in asthma patients with COVID- 19; apply updated evidence and guideline recommendations in the management of mild asthma, with a focus on SMART therapy; and differentiate between difficult-to-treat asthma from severe asthma, and understand the significance of asthma phenotypes and their implications in the treatment of severe asthma.

You’ll also learn about the following:

  • New directions in inhaler use
  • New biologic agents
  • Asthma and allergies
  • How interchangeable are inhaled steroid and bronchodilator brands

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Get Anticoagulant and Antiplatelet Update from CME Webcast

by

OSUWexnerbloglogo2014 Get Anticoagulant and Antiplatelet Update from CME Webcast. We now have many new anticoagulant and antiplatelet drugs for physicians to choose from but more choices means that it can be harder to select the best drug for any given clinical situation. On this CME webcast, we are going to help you pick the best anticoagulant and the best antiplatelet for your patients. We’re pleased to welcome two anticoagulation experts from the Ohio State University. Tiffany Ortman is a clinical pharmacist who will be updating us about anticoagulants. And Danielle Blais is also a clinical pharmacist who will be updating us about antiplatelets.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DETERMINE optimal oral anticoagulant based on patient-specific characteristics; RECOMMENDED monitoring for direct oral anticoagulants; DESCRIBE the role of aspirin and oral P2Y12 inhibitors for patients with stable ischemic heart disease or acute coronary syndromes with or without percutaneous coronary intervention; and EVALUATE the advantages and disadvantages of the different P2Y12 inhibitors.

You’ll also learn about the following:

  • The spectrum of anticoagulants
  • New anti-platelet drugs
  • Direct oral anticoagulant costs and insurance coverage
  • Home INR monitoring

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.